Key result
The INTUITY rapid deployment aortic valve replacement system yielded a 95% technical success rate and shorter crossclamp times compared with historical controls.
Why the study?
Does the INTUITY rapid deployment aortic valve replacement system provide effective hemodynamic performance and reduce procedural times in patients with severe aortic stenosis?
Does the INTUITY rapid deployment aortic valve replacement system provide effective hemodynamic performance and reduce procedural times in patients with severe aortic stenosis?
Answers are grounded in this paper and cite their sources.
The INTUITY rapid deployment aortic valve system demonstrated excellent hemodynamic performance and significantly reduced procedural times, though it was associated with a notable permanent pacemaker implantation rate.
Background The TRANSFORM (Multicen t er Experience With R apid Deployment Edw a rds I N TUITY Valve S ystem for Aortic Valve Replace m ent) trial (NCT01700439) evaluated the performance of the INTUITY rapid deployment aortic valve replacement (RDAVR) system in patients with severe aortic stenosis. Methods TRANSFORM was a prospective, nonrandomized, multicenter (n = 29), single-arm trial. INTUITY is comprised of a cloth-covered balloon-expandable frame attached to a Carpentier-Edwards PERIMOUNT Magna Ease aortic valve. Primary and effectiveness endpoints were evaluated at 1 year. Results Between 2012 and 2015, 839 patients underwent RDAVR. Mean age was 73.5 ± 8.3 years. Full sternotomy (FS) was used in 59% and minimally invasive surgical incisions in 41%. Technical success rate was 95%. For isolated RDAVR, mean crossclamp and cardiopulmonary bypass times for FS were 49.3 ± 26.9 minutes and 69.2 ± 34.7 minutes, respectively, and for minimally invasive surgical 63.1 ± 25.4 minutes and 84.6 ± 33.5 minutes, respectively. These times were favorable compared with Society of Thoracic Surgeons database comparators for FS: 76.3 minutes and 104.2 minutes, respectively, and for minimally invasive surgical, 82.9 minutes and 111.4 minutes, respectively ( P < .001). At 30 days, all-cause mortality was 0.8%; valve explant, 0.1%; thromboembolism, 3.5%; and major bleeding, 1.3%. In patients with isolated aortic valve replacement, the rate of permanent pacemaker implantation was 11.9%. At 1 year, mean effective orifice area was 1.7 cm 2 ; mean gradient, 10.3 mm Hg; and moderate and severe paravalvular leak, 1.2% and 0.4%, respectively. Conclusions INTUITY RDAVR performed effectively in this North American trial. It may lead to a relative reduction in aortic crossclamp time and cardiopulmonary bypass time and has excellent hemodynamic performance. Pacemaker implantation rate observed was somewhat greater than European trials and requires further investigation.
No takes yet. Share an insight, caveat, or question.
Barnhart et al. (2016) studied severe aortic stenosis (n=839). INTUITY rapid deployment aortic valve replacement (RDAVR) system vs. Society of Thoracic Surgeons database comparators was evaluated on mean crossclamp time for full sternotomy (p=<.001). The INTUITY rapid deployment aortic valve replacement system yielded a 95% technical success rate and shorter crossclamp times compared with historical controls.
Synapse has enriched 10 related papers. Consider them for comparative context: